NCT06971406 2025-05-14
FLAME-1
Henan Cancer Hospital
Phase 2 Not yet recruiting
Clinical Trials
3 trialsNCT06441045 2024-06-04
Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT05805631 2024-05-01
Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC
Taipei Veterans General Hospital, Taiwan
Phase 2 Not yet recruiting